Please login to the form below

Not currently logged in
Email:
Password:

Gregory Gallo joins Treato as chief commercial officer

Brings experience from Quest Diagnostics and Johnson & Johnson

Treato Gregory GalloIsrael-based Treato has appointed Gregory Gallo as its new chief commercial officer.

Working out of the online healthcare consumer insights firm's Princeton, New Jersey office, Gallo will be responsible for leading its business solutions unit as well as expanding the firm's global presence in the pharmaceutical industry.

Ido Hadari, Treato's chief executive officer, said: “Greg has a remarkable track record in helping build, lead and scale innovative businesses.

“We are excited to have Greg join our leadership team and look forward to benefitting from his vast knowledge and commercial experience in the healthcare data and analytics field.”

Gallo has over 20 years of commercial experience in the healthcare and pharmaceutical industries, having held senior roles at IntelliSante, ImpactRX, Johnson & Johnson and Quest Diagnostics.

He joins Treato from Activate Networks, now a part of Decision Resources Group, where he served as chief commercial officer and oversaw its commercial operations and growth.

12th February 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics